ST
KERX

Spot Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Spot Trading’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20,000
Closed -$117K – 3519
2016
Q4 		$117K Hold
20,000
– – ﹤0.01% 2150
2016
Q3 		$106K Sell
20,000
-57,000
-74% -$307K ﹤0.01% 2394
2016
Q2 		$510K Sell
77,000
-200
-0.3% -$1.12K 0.01% 1612
2016
Q1 		$361K Buy
+77,200
New +$308K 0.01% 1821
2015
Q3 		– Sell
-6,100
Closed -$61K – 4461
2015
Q2 		$61K Buy
+6,100
New +$65.4K ﹤0.01% 3236
2014
Q4 		– Sell
-900
Closed -$12K – 4605
2014
Q3 		$12K Hold
900
– – ﹤0.01% 4037
2014
Q2 		$14K Sell
900
-119,400
-99% -$1.69M ﹤0.01% 4246
2014
Q1 		$2.05M Buy
120,300
+4,000
+3% +$60.4K 0.01% 1478
2013
Q4 		$1.51M Buy
116,300
+22,100
+23% +$264K 0.01% 1698
2013
Q3 		$950K Sell
94,200
-250,400
-73% -$2.23M 0.01% 1950
2013
Q2 		$2.57M Buy
+344,600
New +$2.69M 0.02% 1177

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

Spot Trading's KERX Position: Q1 2017 in Review

Spot Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q1 2017, closing a stake of 19,646 shares — an estimated $115K sold.

Spot Trading first reported a position in KERX in Q2 2013 and held it in 11 quarters. The position peaked at $3.19M in Q4 2013. 119 funds tracked by Wall St. Rank hold KERX as of Q1 2017.

  • Spot Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 19,646 Keryx Biopharmaceuticals Inc shares in Q1 2017, an estimated $115K.
  • Spot Trading first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
  • Spot Trading's Keryx Biopharmaceuticals Inc position peaked at $3.19M in Q4 2013.
  • 119 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.